First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 2.75 USD -2.14% Market Closed
Updated: Jun 10, 2024
AQST
/
Balance Sheet
/
Accounts Receivables

Aquestive Therapeutics Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
Accounts Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Accounts Receivables
$8.3m
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accounts Receivables
$14.9B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Receivables
$9.2B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
18%
Pfizer Inc
NYSE:PFE
Accounts Receivables
$11B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Accounts Receivables
$11.4B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Accounts Receivables
$7.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
10%

See Also

What is Aquestive Therapeutics Inc's Accounts Receivables?
Accounts Receivables
8.3m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Accounts Receivables amounts to 8.3m USD.

What is Aquestive Therapeutics Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
2%

Over the last year, the Accounts Receivables growth was 10%. The average annual Accounts Receivables growth rates for Aquestive Therapeutics Inc have been -7% over the past three years , 2% over the past five years .

ALPHA SPREAD
Join more than 145,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.